Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPullicino, Edgar-
dc.identifier.citationMalta Medical Journal. 2005, Vol.17(4), p. 22-25en_GB
dc.description.abstractOver the last decade a better understanding of the mechanism for immune disposal of hepatocytes infected with the Hepatitis C virus enabled the design of antiviral regimens with increasing efficacy. The poor rates of sustained viral clearance initially obtained with recombinant interferon (12%) have now improved to over 70 % with the use of a combination of pegylated interferon and the guanosine analogue ribavarine. The relatively poor response of genotype 1 strains to this regimen continues to challenge scientists and clinicians. This article reviews the theoretical and practical aspects of selection of patients for viral eradication, their management during treatment and subsequent follow-up.en_GB
dc.publisherMalta Medical Journalen_GB
dc.subjectHepatitis C -- Eliminationen_GB
dc.subjectHepatitis C -- Treatmenten_GB
dc.subjectAspartate aminotransferaseen_GB
dc.titleEradicating chronic Hepatitis C Viraemia : lessons learnt during the last decadeen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
Appears in Collections:MMJ, Volume 17, Issue 4
MMJ, Volume 17, Issue 4
Scholarly Works - FacM&SMed

Files in This Item:
File Description SizeFormat 
2005.Vol17.Issue4.A3.pdfEradicating chronic Hepatitis C Viraemia: lessons learnt during the last decade81.83 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.